IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vertex Pharmaceuticals Inc

CUSIP: 92532FAN0 | 4 institutional holders

Quarters

Q1 2013Q4 2012Q1 2012
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2013

Palisade Capital Management, LP7,856,000
0.0% of portfolio›$9.5K
Credit Suisse AG/200,000
0.0% of portfolio›$240
StyleTurnoverLocationFiled
Palisade Capital Management, LP
7,856,000$9.5K0.0%CoreLowFort Lee, NJ2013-08-13
Credit Suisse AG/
200,000$2400.0%N/AN/AZurich, Switzerland2013-08-15